FoxWayne Enterprises Acquisition priced its $50 million IPO by offering 5 million units at $10 each.
The SPAC intends to target a biotechnology or telemedicine company in North America.
FoxWayne is led by Chairman, CEO and CFO Robb Knie, who is president, CEO and Chairman of Hoth Therapeutics, a biopharmaceuticals company.
Units begin trading today on the Nasdaq under FOXWU. Read more.
